期刊文献+

磁共振灌注成像在胰腺癌中的应用初探 被引量:14

Application of Magnetic Resonance Perfusion Weighted Imaging in Pancreatic Adenocarcinoma
下载PDF
导出
摘要 探讨磁共振灌注成像在胰腺癌诊断中的应用价值。胰腺癌患者34例,健康志愿者28例,采用VIBE序列进行全胰腺灌注成像,通过胰腺癌和正常胰腺各感兴趣区的时间-信号曲线,计算各感兴趣区的峰值时间(TTP)、最大斜率(SS),比较胰腺癌与正常胰腺的灌注值差别。胰腺癌TTP值为140.24±24.14s、正常胰腺TTP值为24.33±3.74s,两者间有统计学差异(P<0.05);胰腺癌和正常胰腺的SS值分别为16.10±2.20、30.23±4.66,两者间亦有统计学差异(P<0.05)。相对正常胰腺,胰腺癌的TTP显著延长,SS明显降低。磁共振灌注成像可以在活体无创的评估胰腺血供。 To assess the value of MR perfusion weighted imaging in diagnosis of pancreatic adenocarci- noma. Thirty - four patients with pancreatic adenocarcinoma and twenty - eight healthy volunteers underwent MR perfusion with sequence VIBE. A region of interest(ROI) was drawn in adenocarcimoma and normal pancreas respectively, then their time - intensity curves(TIC) were got. The time to peak(TTP) and the steepest slope(SS) were calculated. Then the following statistical analyses were performed: perfusion gained with adenocarcinoma and normal pancreas. The TTP of adenocarcinoma and normal pancreas were 140.24±24.14s, 24.33±3.74s respectively, and the SS 16.10±2.20, 30.23±4.66. There was a significant difference between perfusion of adenocarcinom and normal pancreas(P 〈 0.05) . MR perfnsion weighted imaging can be used to analyze pancreatic blood supply in vivo without invasion. Compared with normal pancreas, pancreatic carcinoma has a prolonged TTP and a lower SS.
出处 《中国医学计算机成像杂志》 CSCD 2008年第6期569-572,共4页 Chinese Computed Medical Imaging
基金 上海市医学领军人才项目(LJ06006) 全军医药卫生科研基金(06MA160)~~
关键词 胰腺癌 磁共振 灌注加权成像 Pancreatic adenocarcinoma Magnetic resonance Perfusion weighted imaging
  • 相关文献

参考文献10

  • 1Muller TB, Haraldseth O, Jones RA, et al. Combined perfusion and diffusion weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion. Stroke, 1995, 26: 451 - 456
  • 2Edelman RR, Wielopolske P, Chmitt F, et al. Echoplanar MR imaging. Radiology, 1994, 192:600
  • 3Kuhl CK, Bieling H, Gieseke J, et al. Breast neoplasms: T2 * susceptibility contrast, first- pass perfusion MR imaging. Radiology, 1997, 202: 87-91
  • 4Verstraete KL, Deene YD, Roels H, et al. Benign and malignant musculoskeletal lesion: dynamic contrast enhanced MR imaging parametric“first - pass” images depict tissue vascularization and perfusion. Radiology, 1994, 192: 835-841
  • 5Kucharczyk J, Mintorovitch J, Asgari HS, et al. Diffusion/ perfusion MR imaging of acute cerebral ischemia. Magn Reson Med, 1991, 19:311-315
  • 6Brix G, Bahner ML, Hoffmann U, et al. Regional blood flow capillary permeability, and compartmental volumes: Measurement with dynamic CT - initial experience. Radiology, 1999, 210: 269 - 276
  • 7Dugdale PE, Miles KA, Bunce I, et al. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr, 1999, 23: 540- 547
  • 8王中秋,黎介寿,卢光明,张新华.胰腺癌的CT增强和瘤体微血管密度及病理分级的相关性研究[J].中华医学杂志,2003,83(21):1882-1886. 被引量:29
  • 9刘悦,李艳英,张在人,王淑红.胰腺癌组织VEGF和MVD表达与CT灌注成像的关系[J].世界华人消化杂志,2006,14(18):1810-1812. 被引量:5
  • 10Pandharipande PV, Krinsky GA, Rusinek H, et al. Perfusion Imaging of the liver: current challenges and future goals. Radiology, 2005, 234: 661-673

二级参考文献49

  • 1王中秋,黎介寿,卢光明,张新华.胰腺癌的CT增强和瘤体微血管密度及病理分级的相关性研究[J].中华医学杂志,2003,83(21):1882-1886. 被引量:29
  • 2Kasper HU,Ebert M,Malfertheiner P,Roessner A,Kirkpatrick CJ,Wolf HK.Expression of thrombospondin-1 in pancreatic carcinoma:correlation with microvessel density.Virchows Arch 2001, 438:116-120
  • 3Bruns CJ,Harbison MT,Davis DW,Portera CA,Tsan R,McConkey DJ,Evans DB,Abbruzzese JL,Hicklin DJ,Radinsky R.Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.Clin Cancer Res 2000, 6:1936-1948
  • 4Bruns CJ,Solorzano CC,Harbison MT,Ozawa S,Tsan R,Fan D,Abbruzzese J,Traxler P,Buchdunger E,Radinsky R,Fidler IJ.Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.Cancer Res 2000, 60:2926-2935
  • 5Bruns CJ,Solorzano CC,Harbison MT,Ozawa S,Tsan R,Fan D,Abbruzzese J,Traxler P,Buchdunger E,Radinsky R,Fidler IJ.Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.Cancer Res 2000, 60:2926-2935
  • 6Folkman J.What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82:4-6
  • 7Okada K,Yokoyama K,Okihara K,Ukimura O,Kojima M,Miki T,Takamatsu T.Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate.Urology 2001, 57:376-381
  • 8Ferrara N,Henzel WJ.Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.Biochem Biophys Res Commun 1989, 161:851-858
  • 9Breier G,Albrecht U,Sterrer S,Risau W.Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.Development 1992, 114:521-532
  • 10Lachgar S,Moukadiri H,Jonca F,Charveron M,Bouhaddioui N,Gall Y,Bonafe JL,Plouet J.Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells.J Invest Dermatol 1996, 106:17-23

共引文献30

同被引文献175

引证文献14

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部